|
Alizyme has raised £10m in a share placing to fund the expansion of its Cambridge-based biopharmaceuticals business. 07-Mar-2008 Alizyme is planning to raise £33m in a share placing to fund the expansion of its Cambridge-based biopharmaceutical development business. 22-Apr-2005 Alizyme has raised a further £11m in a share placing, in order to help negotiate licensing deals for its new drugs. 23-Oct-2003 Alizyme, the biotechnology company, has raised £16m in a share placing and is said to be seeking a licensing partner for its three main products. 29-Jan-2003 Alizyme is planning to increase its investment in drug research and development, using its £22m cash pile. 03-Apr-2001 Alizyme is raising £14m in a share placing in order to fund the development of obesity treatments. 13-Jul-2000 Alizyme is planning to raise £8m in a share placing to fund the development of treatments for obesity and gastrointestinal disorders. 29-Jun-1999 Alizyme claims to have discovered a new compound for the treatment of obesity, and expects to begin clinical development next year. 22-Oct-1998 Alizyme has announced a licensing agreement with SmithKline Beecham for the development of a new treatment for irritable bowel syndrome. 23-Jul-1998 Alizyme has acquired exclusive rights from Yakurigakru Chou Kenkyusho of Japan for the medicinal use of a product derived from rice that is said to inhibit fat digestion. 22-May-1997 Alizyme, the biopharmaceutical company developing drugs for obesity, is planning a share placing on Aim next month in order to raise up to £15m. 25-Jun-1996 Oxford Molecular has announced a research deal with Alizyme in which they will develop compounds to treat obesity. 11-Jun-1996
|